Reported Reactions

Devices › Device types

FDA product code NBC · class 2 · Clinical Chemistry

Test, natriuretic peptide: medical device reports filed with FDA

467 reports carry this product code, 2006–2026; 5 brands with a page.

467
reports with this product code
0% of all MAUDE reports
14
reports, 12 months to August 2026
20 in the 12 months before
85.2%
classified as malfunction
62.3% across all reports
0.6%
classified as death, as reported
0.9% across all reports

Product code NBC is FDA's classification for "Test, natriuretic peptide" (clinical Chemistry panel), a class 2 device. 467 medical device reports carry this product code, 0% of the MAUDE database, from May 2006 to June 2026.

14 reports arrived in the 12 months to August 2026, down 30% from 20 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (85.2%), other (6.9%) and injury (6.2%). 5 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Triage Cardiac Panel 25 Test5401.3%80.3%
Triage Cardiac Profiler Kit2500%79.2%
Advia Centaur Cp100%94.7%
Elecsys 2010 Rack100%98.3%
VITROS 5600 Integrated System1190%97.5%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Alere San Diego19241.1%
Biosite429%
Abbott Laboratories143%
Beckman Coulter20.4%
Ortho Clinical Diagnostics10.2%

Reports by month, five years

036Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 1Jun 2022: 0Jul 2022: 0Aug 2022: 1Sep 2022: 1Oct 2022: 1Nov 2022: 0Dec 2022: 02023Jan 2023: 2Feb 2023: 2Mar 2023: 5Apr 2023: 0May 2023: 4Jun 2023: 5Jul 2023: 1Aug 2023: 1Sep 2023: 1Oct 2023: 3Nov 2023: 0Dec 2023: 22024Jan 2024: 1Feb 2024: 1Mar 2024: 1Apr 2024: 0May 2024: 2Jun 2024: 2Jul 2024: 1Aug 2024: 1Sep 2024: 2Oct 2024: 2Nov 2024: 1Dec 2024: 02025Jan 2025: 1Feb 2025: 5Mar 2025: 6Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 1Aug 2025: 2Sep 2025: 1Oct 2025: 0Nov 2025: 0Dec 2025: 12026Jan 2026: 1Feb 2026: 3Mar 2026: 3Apr 2026: 4May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0.6%3
Injury6.2%29
Malfunction85.2%398
Other6.9%32
Not given1.1%5

Who filed

Manufacturer report99.1%463
Voluntary report0.2%1
User facility report0%0
Distributor report0%0
Not given0.6%3

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Low test results17136.6%
High test results8217.6%
Incorrect or inadequate test results7015%
Incorrect, inadequate or imprecise result or readings5411.6%
False negative result5211.1%
False positive result388.1%
Non reproducible results245.1%
Device operates differently than expectedthe device behaved unexpectedly91.9%
Low readingsreadings were too low51.1%
Improper or incorrect procedure or method40.9%
Device issuea problem with the device30.6%
Failure to calibrate30.6%
High readingsreadings were too high30.6%
Temperature problem30.6%
Component missing20.4%
Device emits odor20.4%
Failure to power up20.4%
Insufficient device problem information20.4%
Nonstandard device20.4%
Smoking20.4%

Questions about test, natriuretic peptide reports

What is product code NBC?

FDA's classification code for "Test, natriuretic peptide", class 2, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.

How many reports carry this code?

467 reports through August 2026, 14 of them in the latest 12 months.

Which brands appear most often?

Triage Cardiac Panel 25 Test (54), Triage Cardiac Profiler Kit (25), Advia Centaur Cp (1), Elecsys 2010 Rack (1) and VITROS 5600 Integrated System (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.